ArticleBMC cardiovascular disorders2026
Temporal and spatial variation in hospitalizations and mortality from acute myocardial infarction in Brazil during the COVID-19 pandemic period (2020-2023).
Article in BMC cardiovascular disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe COVID-19 pandemic emerged as a major public health challenge, not only due to the high number of victims but also because of the significant rise in cardiovascular emergencies associated with the infection. We investigated the temporal and spatial variation in hospitalizations (2020-2023) and deaths (2020-2022) from Acute Myocardial Infarction (AMI) in Brazil during the COVID-19 pandemic.
methodsWe analyzed hospitalizations (between 2015 and 2023) and deaths (between 2015 and 2022), using data from the Mortality Information System (SIM) and the Hospital Information System (SIH) of the Brazilian Ministry of Health. Percentage change was calculated to assess whether there was an increase or decrease in hospitalizations and deaths from AMI, considering the average of the previous five years. Additionally, a Joinpoint regression model was applied to evaluate temporal trends before and after the onset of the pandemic. Spatial variations were visualized through choropleth maps.
resultsA consistent rise in AMI hospitalizations was observed nationwide, with percentage increases of 13.4% in 2020, 21.2% in 2021, 36.9% in 2022, and 30.9% in 2023. The Central-West region showed the highest growth rates. Regarding mortality, there was a reduction in AMI deaths in 2020 (-3.0%), followed by increases in 2021 (2.2%) and 2022 (4.6%), particularly in the North and Central-West regions. Temporal trend analysis revealed a significant increase in AMI hospitalizations in Brazil (APC = 5.7%; p < 0.05). The most pronounced growth was observed in the Central-West (APC = 10.4%; p < 0.05) and North (APC = 6.3%; p < 0.05) regions. For mortality, trends were stable during the pre-pandemic period in Brazil and in most regions, but they increased in the pandemic period in the North (APC = 2.6%; p < 0.05) and Central-west (APC = 1.6%; p < 0.05) regions.
conclusionOverall, this study identified an increase in the number of hospitalizations (between 2020 and 2023) and deaths (between 2020 and 2022) due to AMI in Brazil, highlighting COVID-19's significant impact on cardiovascular health. The findings underscore the urgent need for stronger investments in health infrastructure, as well as strategic interventions to mitigate the effects of the pandemic and reduce hospitalizations and deaths in the coming years.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.